UA40573C2 - Похідні 2-ціано-3-гідроксипропенаміду, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі - Google Patents

Похідні 2-ціано-3-гідроксипропенаміду, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі

Info

Publication number
UA40573C2
UA40573C2 UA94005036A UA94005036A UA40573C2 UA 40573 C2 UA40573 C2 UA 40573C2 UA 94005036 A UA94005036 A UA 94005036A UA 94005036 A UA94005036 A UA 94005036A UA 40573 C2 UA40573 C2 UA 40573C2
Authority
UA
Ukraine
Prior art keywords
radical
atoms
carbon
atom
hydroxypropenamide
Prior art date
Application number
UA94005036A
Other languages
English (en)
Russian (ru)
Inventor
Елізабет Анн Кюо
Элизабет Анн Кюо
Original Assignee
Хьохст Маріон Руссель
Хехст Марион Руссель
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хьохст Маріон Руссель, Хехст Марион Руссель filed Critical Хьохст Маріон Руссель
Publication of UA40573C2 publication Critical patent/UA40573C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Винахід належить до похідних 2-ціано-3-гідроксіпропенаміду, їхніх таутомерних форм і їхніх солей, до способу їх отримання (і до варіанту його здійснення), а також до фармацевтичної композиції на їх основі. Похідні 2-ціано-З-гідроксіпропенаміду, що відповідають загальній формулі (I): в якій: А, В і Ε кожний являє собою групу =СН- або атом азоту, причому слід мати на увазі, що як мінімум один з А, В або Ε є атомом азоту, R являє собою циклоалкільний радикал, що включає від 3 до 6 атомів вуглецю, алкільний радикал, що включає від 2 до 6 атомів вуглецю, алкінільний радикал, що включає від 2 до 6 атомів вуглецю, R1 являє собою атом водню, алкільний радикал, що включає від 1 до 3 атомів вуглецю, R2 і R3, однакові або різні, являють собою. атом водню., атом галогену, ціаногрупу, нітрогрупу, лінійний або розгалужений алкільний радикал, що включає від 1 до 6 атомів вуглецю, циклоалкільний радикал, що включає від 3 до 6 атомів вуглецю, лінійний або розгалужений алкоксильний радикал, що включає від 1 до 6 атомів вуглецю, алкілтіонільний радикал, що включає від 1 до 6 атомів вуглецю, радикал -(СН2)m-СХ3, радикал -О-(СН2)m-СХ3, радикал -S-(CH2)m-CX3, радикал -О-(СХ2)m-СХ3, радикал -S-(CX2)m-CX3, в яких m набуває цілочисленного значення від 0 до 3, а X являє собою атом галогену або групу -CO-R4, в якій R4 являє собою атом водню, лінійний або розгалужений алкільний радикал, що включає від 1 до 6 атомів вуглецю, циклоалкільний радикал, що включає від 3 до 6 атомів вуглецю, або ж R2 і R3 утворюють разом групу -О-СН2-О-, їх таутомерні форми, а також їх аддитивні солі з неорганічними або органічними основами.
UA94005036A 1993-01-05 1994-01-04 Похідні 2-ціано-3-гідроксипропенаміду, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі UA40573C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939300083A GB9300083D0 (en) 1993-01-05 1993-01-05 Chemical compounds

Publications (1)

Publication Number Publication Date
UA40573C2 true UA40573C2 (uk) 2001-08-15

Family

ID=10728304

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94005036A UA40573C2 (uk) 1993-01-05 1994-01-04 Похідні 2-ціано-3-гідроксипропенаміду, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі

Country Status (33)

Country Link
US (1) US5346912A (uk)
EP (1) EP0606175B1 (uk)
JP (1) JP3334988B2 (uk)
KR (1) KR100295717B1 (uk)
CN (1) CN1042935C (uk)
AT (1) ATE128968T1 (uk)
AU (1) AU663017B2 (uk)
BR (1) BR9400017A (uk)
CA (1) CA2112866C (uk)
CZ (1) CZ283948B6 (uk)
DE (1) DE69400024T2 (uk)
DK (1) DK0606175T3 (uk)
EE (1) EE03001B1 (uk)
ES (1) ES2078130T3 (uk)
FI (1) FI106553B (uk)
GB (1) GB9300083D0 (uk)
GR (1) GR3017723T3 (uk)
HR (1) HRP940006B1 (uk)
HU (1) HU216835B (uk)
IL (1) IL107788A (uk)
LT (1) LT3766B (uk)
LV (1) LV10712B (uk)
MX (1) MX9400274A (uk)
NO (1) NO300839B1 (uk)
NZ (1) NZ250520A (uk)
PL (1) PL175135B1 (uk)
RU (1) RU2126387C1 (uk)
SI (1) SI9300686A (uk)
SK (1) SK280508B6 (uk)
TW (1) TW259785B (uk)
UA (1) UA40573C2 (uk)
YU (1) YU49047B (uk)
ZA (1) ZA939118B (uk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338804A1 (en) * 1998-07-28 2000-02-10 Smithkline Beecham Corporation Propenamides as ccr5 modulators
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
MX2010001462A (es) 2007-08-27 2010-03-01 Basf Se Compuestos de pirazol para controlar plagas de invertebrados.
US8729083B2 (en) 2008-09-24 2014-05-20 Basf Se Pyrazole compounds for controlling invertebrate pests
US9029639B2 (en) 2009-07-06 2015-05-12 Basf Se Pyridazine compounds for controlling invertebrate pests
EP2451808B1 (en) 2009-07-06 2014-03-26 Basf Se Pyridazine compounds for controlling invertebrate pests
EP2456308A2 (en) 2009-07-24 2012-05-30 Basf Se Pyridine derivatives for controlling invertrebate pests
KR20160079123A (ko) 2013-11-22 2016-07-05 젠자임 코포레이션 신경변성 질병을 치료하기 위한 신규한 방법
CN105693574B (zh) * 2014-11-25 2017-12-19 中国科学院大连化学物理研究所 2‑烷硫基烯酰胺衍生物及其合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4435407A (en) * 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
DE3534440A1 (de) 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US4888357A (en) 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
IL92508A0 (en) * 1988-12-08 1990-08-31 Ciba Geigy Ag Novel alpha-cyano-beta-oxopropionamides
AU649421B2 (en) * 1990-05-18 1994-05-26 Sanofi-Aventis Deutschland Gmbh Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf History of 3-cycloalkyl-prop-2-anamide

Also Published As

Publication number Publication date
TW259785B (en) 1995-10-11
EP0606175B1 (fr) 1995-10-11
RU94000064A (ru) 1996-07-10
PL175135B1 (pl) 1998-11-30
CN1097005A (zh) 1995-01-04
HRP940006A2 (en) 1996-10-31
HU9400033D0 (en) 1994-05-30
CA2112866C (fr) 2007-03-13
DK0606175T3 (da) 1996-02-19
ATE128968T1 (de) 1995-10-15
PL301774A1 (en) 1994-07-11
DE69400024D1 (de) 1995-11-16
LT3766B (en) 1996-03-25
GR3017723T3 (en) 1996-01-31
YU82593A (sh) 1996-07-24
CZ292193A3 (en) 1994-07-13
HU216835B (hu) 1999-09-28
IL107788A (en) 1998-08-16
EE03001B1 (et) 1997-06-16
SK280508B6 (sk) 2000-03-13
SI9300686A (en) 1994-09-30
FI106553B (fi) 2001-02-28
EP0606175A1 (fr) 1994-07-13
NO940020L (uk) 1994-07-06
HRP940006B1 (en) 1999-12-31
CA2112866A1 (fr) 1994-07-06
HUT71471A (en) 1995-11-28
NO300839B1 (no) 1997-08-04
YU49047B (sh) 2003-07-07
KR100295717B1 (ko) 2001-11-05
NZ250520A (en) 1996-08-27
ZA939118B (en) 1995-01-18
CZ283948B6 (cs) 1998-07-15
JP3334988B2 (ja) 2002-10-15
GB9300083D0 (en) 1993-03-03
DE69400024T2 (de) 1996-04-04
ES2078130T3 (es) 1995-12-01
MX9400274A (es) 1994-08-31
FI940031A (fi) 1994-07-06
NO940020D0 (no) 1994-01-04
RU2126387C1 (ru) 1999-02-20
LTIP1634A (en) 1995-02-27
IL107788A0 (en) 1994-02-27
CN1042935C (zh) 1999-04-14
US5346912A (en) 1994-09-13
AU663017B2 (en) 1995-09-21
LV10712B (en) 1995-12-20
KR940018363A (ko) 1994-08-16
AU5213093A (en) 1994-07-14
SK149593A3 (en) 1994-12-07
JPH06211793A (ja) 1994-08-02
LV10712A (lv) 1995-06-20
FI940031A0 (fi) 1994-01-04
BR9400017A (pt) 1994-08-02

Similar Documents

Publication Publication Date Title
HUT65618A (en) Process for producing benzylidene-carbamoyl-2-pyrrolidone, -4-oxazolidinone, -4-thiazolidinone and -3-isothiazolidinone analogues
NO955023L (no) Piperidinderivater og fremgangsmåte for fremstilling derav
DE69532245D1 (en) Imidazolderivat
NO923256L (no) Pyrrolidyltiokarbapenemderivat
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
GB9308487D0 (en) Novel compounds
UA40573C2 (uk) Похідні 2-ціано-3-гідроксипропенаміду, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
MY105950A (en) 4-acyloxyquinoline derivatives and insecticidal or acaricidal compositions containing same.
ATE127123T1 (de) Biphosphonsäurederivate, produktion und verwendung davon.
DE68910211D1 (de) Estramustin-ester.
CY1107937T1 (el) Προφαρμακα σε συνδετες υποδοχεα nmda
ES2169220T3 (es) Derivados de vitamina d3 con sustituyentes en la posicion 2.
CA2221946A1 (en) Production process of cyclic compound
MX9505054A (es) Derivados de ester de bisfenol.
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
NO913769D0 (no) Forbindelse, fremstilling og anvendelse.
NO913768L (no) Forbindelse, anvendelse og fremstilling.
ATE133677T1 (de) Bisphosphonsäurederivate, ihre produktion und ihre verwendung
BG101942A (en) Analogues of arginine having inhibiting activity on no-synthetase
MY106898A (en) Aromatic compounds, their production processes and their compositions for the control of insect pests
DE3879058D1 (de) 4-piperidincarboxamid-derivate.
TW216417B (en) Carboxylic acid derivative having retinoid type pharmacological activities
MY134476A (en) Aromatic compounds, their production processes and their compositions for the control of insect pests
TW360627B (en) Cyclopentadienyl derivatives and process for the preparation
TR200003654T2 (tr) 3-(2-okso-(1,3')bipirolidinil-3-ilidenemetil)-sefem türevleri.